| MeSH term | MeSH ID | Detail |
|---|---|---|
| Prosthesis-Related Infections | D016459 | 7 associated lipids |
| Fibrosis | D005355 | 23 associated lipids |
| Tooth Discoloration | D014075 | 7 associated lipids |
| Sinusitis | D012852 | 9 associated lipids |
| Fusobacterium Infections | D005674 | 3 associated lipids |
| Enterocolitis, Pseudomembranous | D004761 | 8 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Urinary Tract Infections | D014552 | 11 associated lipids |
| Cross Infection | D003428 | 9 associated lipids |
| Pseudomonas Infections | D011552 | 25 associated lipids |
clarithromycin
clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.
Cross Reference
Introduction
To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with clarithromycin?
clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (63)
- J. Antimicrob. Chemother. (56)
- J. Clin. Microbiol. (39)
- Others (258)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with clarithromycin
PubChem Associated disorders and diseases
What pathways are associated with clarithromycin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with clarithromycin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- J. Antimicrob. Chemother. (25)
- Antimicrob. Agents Chemother. (20)
- J. Clin. Microbiol. (9)
- Others (66)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with clarithromycin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with clarithromycin?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (5)
- Drug Metab. Dispos. (1)
- FEMS Immunol. Med. Microbiol. (1)
- Others (5)
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with clarithromycin?
Related references are published most in these journals:
- J. Antimicrob. Chemother. (20)
- Antimicrob. Agents Chemother. (17)
- J. Clin. Microbiol. (13)
- Others (57)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with clarithromycin?
Mouse Model
Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).
Knock-out
Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).
Experimental Pneumococcal Meningitis
Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with clarithromycin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Gotfried MH | Clarithromycin (Biaxin) extended-release tablet: a therapeutic review. | 2003 | Expert Rev Anti Infect Ther | pmid:15482099 |
| Hammerschlag MR | Advances in the management of Chlamydia pneumoniae infections. | 2003 | Expert Rev Anti Infect Ther | pmid:15482145 |
| Kuehne JJ et al. | Corneal pharmacokinetics of topically applied azithromycin and clarithromycin. | 2004 | Am. J. Ophthalmol. | pmid:15488779 |
| Cinar K et al. | The effect of Helicobacter pylori eradication in patients with functional dyspepsia: assessment of different diagnostic tests. | 2004 | Turk J Gastroenterol | pmid:15492914 |
| Rollot F et al. | Acute colchicine intoxication during clarithromycin administration. | 2004 | Ann Pharmacother | pmid:15494379 |
| Gerrits MM et al. | Role of the rdxA and frxA genes in oxygen-dependent metronidazole resistance of Helicobacter pylori. | 2004 | J. Med. Microbiol. | pmid:15496391 |
| Koytchev R et al. | Studies on the bioequivalence of different strengths of tablets containing clarithromycin. | 2004 | Arzneimittelforschung | pmid:15497665 |
| Koytchev R et al. | Clarithromycin suspension: bioequivalence studies on two different strengths. | 2004 | Arzneimittelforschung | pmid:15497666 |
| Coelho LG et al. | [Efficacy of the dosing regimen of pantoprazole 40 mg, amoxicillin 1000 mg and clarithromycin 500 mg, twice daily for 7 days, in the eradication of Helicobacter pylori in patients with peptic ulcer]. | 2004 Jan-Mar | Arq Gastroenterol | pmid:15499429 |
| Raymond J et al. | Genetic and transmission analysis of Helicobacter pylori strains within a family. | 2004 | Emerging Infect. Dis. | pmid:15504269 |
| Piersimoni C et al. | Mycobacterium triplex pulmonary disease in immunocompetent host. | 2004 | Emerging Infect. Dis. | pmid:15504279 |
| Ferguson DD et al. | Mycobacterium goodii infections associated with surgical implants at Colorado hospital. | 2004 | Emerging Infect. Dis. | pmid:15504281 |
| Matic V et al. | Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin. | 2004 | Antimicrob. Agents Chemother. | pmid:15504828 |
| Kosowska K et al. | Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae. | 2004 | Antimicrob. Agents Chemother. | pmid:15504829 |
| Berg HF et al. | Emergence and persistence of macrolide resistance in oropharyngeal flora and elimination of nasal carriage of Staphylococcus aureus after therapy with slow-release clarithromycin: a randomized, double-blind, placebo-controlled study. | 2004 | Antimicrob. Agents Chemother. | pmid:15504839 |
| Kwon KT et al. | [The diagnostic validity of Helicobacter pylori stool antigen test in the pre- and post-eradication]. | 2004 | Korean J Gastroenterol | pmid:15505431 |
| Maaroos HI et al. | The diagnostic value of endoscopy and Helicobacter pylori tests for peptic ulcer patients in late post-treatment setting. | 2004 | BMC Gastroenterol | pmid:15507141 |
| Fukuda Y and Sakagami T | [The several problems and cautions in treatment of Helicobacter pylori infection]. | 2004 | Gan To Kagaku Ryoho | pmid:15508434 |
| Maciorkowska E et al. | [Resistance to antibiotics used in Helicobacter pylori infection in children]. | 2004 | Pol. Merkur. Lekarski | pmid:15510893 |
| Gomollón F et al. | [Helicobacter pylori resistance to metronidazole and clarythromicin: descriptive analysis 1997-2000]. | 2004 | Med Clin (Barc) | pmid:15511367 |
| Chan JW and Lee S | SARS patients and need for treatment. | 2004 | Emerging Infect. Dis. | pmid:15515244 |
| Ono T et al. | In vitro and in vivo antibacterial activities of the tricyclic ketolide TE-802 and its analogs. | 2004 | J. Antibiot. | pmid:15515889 |
| Jacobson TA | Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors. | 2004 | Am. J. Cardiol. | pmid:15518608 |
| Branca G et al. | High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy. | 2004 | Int. J. Antimicrob. Agents | pmid:15519473 |
| Chen HH et al. | Successive development of cutaneous polyarteritis nodosa, leucocytoclastic vasculitis and Sweet's syndrome in a patient with cervical lymphadenitis caused by Mycobacterium fortuitum. | 2004 | Br. J. Dermatol. | pmid:15541094 |
| Kyle SD and Porter WM | Mycobacterium chelonae infection successfully treated with oral clarithromycin and linezolid. | 2004 | Br. J. Dermatol. | pmid:15541095 |
| Chatterjee A et al. | Inhibition of Helicobacter pylori in vitro by various berry extracts, with enhanced susceptibility to clarithromycin. | 2004 | Mol. Cell. Biochem. | pmid:15543930 |
| Jain R and Danziger LH | The macrolide antibiotics: a pharmacokinetic and pharmacodynamic overview. | 2004 | Curr. Pharm. Des. | pmid:15544496 |
| Jacobs MR | Fluoroquinolones as chemotherapeutics against mycobacterial infections. | 2004 | Curr. Pharm. Des. | pmid:15544510 |
| Bermudez LE and Yamazaki Y | Effects of macrolides and ketolides on mycobacterial infections. | 2004 | Curr. Pharm. Des. | pmid:15544511 |
| Befrits R et al. | Long-term effects of eradication of Helicobacter pylori on relapse and histology in gastric ulcer patients: a two-year follow-up study. | 2004 | Scand. J. Gastroenterol. | pmid:15545163 |
| Cooksey RC et al. | Mycobacterium cosmeticum sp. nov., a novel rapidly growing species isolated from a cosmetic infection and from a nail salon. | 2004 | Int. J. Syst. Evol. Microbiol. | pmid:15545488 |
| Trieu J et al. | Rhabdomyolysis resulting from interaction of simvastatin and clarithromycin demonstrated by Tc-99m MDP scintigraphy. | 2004 | Clin Nucl Med | pmid:15545884 |
| Destura RV et al. | Laboratory diagnosis and susceptibility profile of Helicobacter pylori infection in the Philippines. | 2004 | Ann. Clin. Microbiol. Antimicrob. | pmid:15546485 |
| Cao X et al. | Eradication of Helicobacter pylori induces apoptosis and inhibits proliferation of heterotopic proliferative glands in infected Mongolian gerbils. | 2004 | Cancer Sci. | pmid:15546504 |
| Vergara-López S et al. | [Digoxin toxicity secondary to inhibition of digoxin intestinal metabolism in a patient receiving clarithromycin]. | 2004 | Med Clin (Barc) | pmid:15546530 |
| Iwasaki K et al. | Effect of water intake on pharmacokinetics of lansoprazole from fast disintegrating tablet in human subjects. | 2004 | Drug Metab. Pharmacokinet. | pmid:15548851 |
| Shimoyama T et al. | Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population. | 2004 | J. Gastroenterol. | pmid:15549444 |
| Bilardi C et al. | A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial. | 2004 | Clin. Gastroenterol. Hepatol. | pmid:15551252 |
| Chen B et al. | [Pulmonary disease caused by nontuberculous mycobacteria after allogeneic hematopoietic stem cell transplantation--a case report and literature review]. | 2004 | Zhonghua Xue Ye Xue Za Zhi | pmid:15555262 |
| Sketris IS et al. | Comparison of anti-infective drug use in elderly persons in Manitoba, Nova Scotia, and Saskatchewan, Canada: relationship to drug insurance reimbursement policies. | 2004 | Am J Geriatr Pharmacother | pmid:15555476 |
| Lang L and GarcÃa F | Comparison of E-test and disk diffusion assay to evaluate resistance of Helicobacter pylori isolates to amoxicillin, clarithromycin, metronidazole and tetracycline in Costa Rica. | 2004 | Int. J. Antimicrob. Agents | pmid:15555880 |
| Buzás GM and Józan J | [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002]. | 2004 | Orv Hetil | pmid:15559530 |
| Isakov VA | [Proton pump inhibitors as the basis of anti-helicobacter therapeutic schemes]. | 2004 | Eksp Klin Gastroenterol | pmid:15560400 |
| Watanabe K et al. | Effect of sucralfate on antibiotic therapy for Helicobacter pylori infection in mice. | 2004 | Antimicrob. Agents Chemother. | pmid:15561829 |
| Kim JM et al. | Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea. | 2004 | Antimicrob. Agents Chemother. | pmid:15561865 |
| Carter G et al. | A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation. | 2004 | Antimicrob. Agents Chemother. | pmid:15561879 |
| Jones TC et al. | Cough and fear of sleep: early clinical signs of Bordetella pertussis in an adult. | 2004 | Braz J Infect Dis | pmid:15565264 |
| Fukuda S et al. | Effect of Helicobacter pylori eradication in the treatment of Japanese patients with chronic idiopathic urticaria. | 2004 | J. Gastroenterol. | pmid:15565400 |
| Kato S et al. | Results of triple eradication therapy in Japanese children: a retrospective multicenter study. | 2004 | J. Gastroenterol. | pmid:15565402 |
| Shirai M et al. | [Outcome of pulmonary Mycobacterium avium complex (MAC) disease treated with clarithromycin (CAM)-containing regimens]. | 2004 | Nihon Kokyuki Gakkai Zasshi | pmid:15566000 |
| Kasai S et al. | [A case of bronchial ulcer due to infection by Mycobacterium abscessus]. | 2004 | Nihon Kokyuki Gakkai Zasshi | pmid:15566008 |
| Buzás GM | [The effect of Helicobacter pylori eradication on prokinetic treatment on the quality of life in functional dyspepsia]. | 2004 | Orv Hetil | pmid:15566071 |
| File TM and Tillotson GS | Gemifloxacin: a new, potent fluoroquinolone for the therapy of lower respiratory tract infections. | 2004 | Expert Rev Anti Infect Ther | pmid:15566328 |
| Fischbach LA et al. | Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies. | 2004 | Aliment. Pharmacol. Ther. | pmid:15569109 |
| Nista EC et al. | Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. | 2004 | Aliment. Pharmacol. Ther. | pmid:15569121 |
| Aurangzeb B and Hameed A | Comparative efficacy of amoxicillin, cefuroxime and clarithromycin in the treatment of community -acquired pneumonia in children. | 2003 | J Coll Physicians Surg Pak | pmid:15569557 |
| Kato A et al. | [Evaluation of the efficacy of an Helicobacter pylori eradication treatment for idiopathic thrombocytopenic purpura patients]. | 2004 | Nihon Shokakibyo Gakkai Zasshi | pmid:15570869 |
| Spengler G et al. | The antimotility action of a trifluoromethyl ketone on some gram-negative bacteria. | 2004 | Acta Microbiol Immunol Hung | pmid:15571074 |
| Miravitlles M and Torres A | Antibiotics in exacerbations of COPD: lessons from the past. | 2004 | Eur. Respir. J. | pmid:15572528 |
| Lode H et al. | Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval. | 2004 | Eur. Respir. J. | pmid:15572537 |
| Kido H et al. | Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential. | 2004 | Biol. Chem. | pmid:15576322 |
| Nagahara A et al. | Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen. | 2004 | J. Gastroenterol. | pmid:15580397 |
| Tamaoki J et al. | Clinical implications of the immunomodulatory effects of macrolides. | 2004 | Am. J. Med. | pmid:15586558 |
| Siddiqui J | Immunomodulatory effects of macrolides: implications for practicing clinicians. | 2004 | Am. J. Med. | pmid:15586561 |
| Llor C et al. | Economic evaluation of the antibiotic treatment of exacerbations of chronic bronchitis and COPD in primary care. | 2004 | Int. J. Clin. Pract. | pmid:15587773 |
| Wu AK et al. | The unmasking of Pneumocystis jiroveci pneumonia during reversal of immunosuppression: case reports and literature review. | 2004 | BMC Infect. Dis. | pmid:15588295 |
| Pilotto A | Aging and upper gastrointestinal disorders. | 2004 | Best Pract Res Clin Gastroenterol | pmid:15588798 |
| Nash KA et al. | Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum. | 2005 | J. Antimicrob. Chemother. | pmid:15590712 |
| Amsden GW | Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? | 2005 | J. Antimicrob. Chemother. | pmid:15590715 |
| Marra F et al. | Effect of formulary policy decisions on antimicrobial drug utilization in British Columbia. | 2005 | J. Antimicrob. Chemother. | pmid:15590717 |
| Winter HR et al. | The effect of clarithromycin, fluconazole, and rifabutin on dapsone hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283). | 2004 | Clin. Pharmacol. Ther. | pmid:15592329 |
| Regnath T et al. | [Real-time PCR assay for rapid detection of clarithromycin-resistant helicobacter pylori in gastric biopsy specimens]. | 2004 | Z Gastroenterol | pmid:15592960 |
| Mah-Sadorra JH et al. | Mycobacterium chelonae wound ulcer after clear-cornea cataract surgery. | 2004 | Arch. Ophthalmol. | pmid:15596600 |
| Ishii K et al. | Comparative study of pharmacokinetic parameters between clarithromycin and erythromycin stearate in relation to their physicochemical properties. | 1998 | Drug Dev Ind Pharm | pmid:15605442 |
| Wilms E et al. | Quantitative determination of azithromycin in plasma, blood and isolated neutrophils by liquid chromatography using pre-column derivatization with 9-fluorenylmethyloxycarbonyl-chloride and fluorescence detection. | 2005 | J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. | pmid:15607705 |
| Mateo L et al. | Mycobacterium chelonae tenosynovitis of the hand. | 2004 | Semin. Arthritis Rheum. | pmid:15609266 |
| McCormack PL and Keating GM | Amoxicillin/clavulanic acid 2000mg/125mg extended release (XR): a review of its use in the treatment of respiratory tract infections in adults. | 2005 | Drugs | pmid:15610061 |
| Kanai K et al. | Growth competition of macrolide-resistant and -susceptible Helicobacter pylori strains. | 2004 | Microbiol. Immunol. | pmid:15611615 |
| Marrie TJ et al. | Symptom resolution in patients with Mycoplasma pneumoniae pneumonia. | 2004 Nov-Dec | Can. Respir. J. | pmid:15611807 |
| Weiss K et al. | Clinical characteristics at initial presentation and impact of dual therapy on the outcome of bacteremic Streptococcus pneumoniae pneumonia in adults. | 2004 Nov-Dec | Can. Respir. J. | pmid:15611810 |
| Hajjaji N et al. | [Mycobacterium chelonae myositis]. | 2004 | Presse Med | pmid:15614176 |
| Suzuki A et al. | CYP isoforms involved in the metabolism of clarithromycin in vitro: comparison between the identification from disappearance rate and that from formation rate of metabolites. | 2003 | Drug Metab. Pharmacokinet. | pmid:15618724 |
| Gunaid AA et al. | Recurrence of Helicobacter pylori infection 1 year after successful treatment: prospective cohort study in the Republic of Yemen. | 2004 | Eur J Gastroenterol Hepatol | pmid:15618837 |
| Jönsson M et al. | Clarithromycin treatment selects for persistent macrolide-resistant bacteria in throat commensal flora. | 2005 | Int. J. Antimicrob. Agents | pmid:15620829 |
| Querol-Ribelles JM et al. | Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization. | 2005 | Int. J. Antimicrob. Agents | pmid:15620830 |
| Tokgöz B et al. | Effects of azithromycin on cyclosporine-induced gingival hyperplasia in renal transplant patients. | 2004 | Transplant. Proc. | pmid:15621128 |
| Jacobs P et al. | Immune agranulocytosis and clarithromycin. | 2004 | Hematology | pmid:15621737 |
| Job V et al. | [Medical-surgical treatment of pulmonary infection with Mycobacterium malmoense]. | 2004 | Rev Mal Respir | pmid:15622347 |
| Kurekci AE et al. | Complete platelet recovery after treatment of Helicobacter pylori infection in a child with chronic immune thrombocytopenic purpura: a case report. | 2004 Oct-Nov | Pediatr Hematol Oncol | pmid:15626015 |
| Chen J et al. | [Prevalence and mechanism of Helicobacter pylori resistance to clarithromycin in children]. | 2004 | Zhonghua Er Ke Za Zhi | pmid:15631715 |
| Hua CZ et al. | [Serotypes and antibiotics-resistance patterns of 247 strains of Haemophilus Influenzae isolated from children in Hangzhou]. | 2004 | Zhonghua Er Ke Za Zhi | pmid:15631716 |
| Coulston J and Balaratnam N | Irreversible sensorineural hearing loss due to clarithromycin. | 2005 | Postgrad Med J | pmid:15640431 |
| Wong WM et al. | Standard treatment for Helicobacter pylori infection is suboptimal in non-ulcer dyspepsia compared with duodenal ulcer in Chinese. | 2005 | Aliment. Pharmacol. Ther. | pmid:15644048 |
| Appelbaum PC et al. | Activity of the new quinolone WCK 771 against pneumococci. | 2005 | Clin. Microbiol. Infect. | pmid:15649298 |
| Morrissey I et al. | Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods. | 2005 | J. Antimicrob. Chemother. | pmid:15649996 |
| Fujimori K et al. | Effect of Helicobacter pylori eradication on ongoing mutation of immunoglobulin genes in gastric MALT lymphoma. | 2005 | Br. J. Cancer | pmid:15655559 |
| Barker PM et al. | Effect of macrolides on in vivo ion transport across cystic fibrosis nasal epithelium. | 2005 | Am. J. Respir. Crit. Care Med. | pmid:15657462 |
| Fouts DE et al. | Major structural differences and novel potential virulence mechanisms from the genomes of multiple campylobacter species. | 2005 | PLoS Biol. | pmid:15660156 |
| Kandemir O et al. | Clarithromycin destroys biofilms and enhances bactericidal agents in the treatment of Pseudomonas aeruginosa osteomyelitis. | 2005 | Clin. Orthop. Relat. Res. | pmid:15662320 |